Xiaofeng Jin

2.3k total citations
90 papers, 1.5k citations indexed

About

Xiaofeng Jin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofeng Jin has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 25 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofeng Jin's work include Ubiquitin and proteasome pathways (36 papers), Cancer-related Molecular Pathways (14 papers) and Histone Deacetylase Inhibitors Research (11 papers). Xiaofeng Jin is often cited by papers focused on Ubiquitin and proteasome pathways (36 papers), Cancer-related Molecular Pathways (14 papers) and Histone Deacetylase Inhibitors Research (11 papers). Xiaofeng Jin collaborates with scholars based in China, United States and Taiwan. Xiaofeng Jin's co-authors include Ri‐He Peng, Xiaoyan Fu, Jing Zhuang, Ai‐Sheng Xiong, Feng Gao, Yushan Qiao, Bin Cai, Yong‐Sheng Tian, Wei Zhao and Haojie Huang and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncogene.

In The Last Decade

Xiaofeng Jin

86 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofeng Jin China 21 1.1k 424 274 168 136 90 1.5k
Xiaojun Zha China 20 1.0k 0.9× 321 0.8× 582 2.1× 208 1.2× 148 1.1× 53 1.6k
Dadong Zhang China 19 534 0.5× 570 1.3× 205 0.7× 142 0.8× 80 0.6× 41 1.3k
Fangfang Liu China 24 761 0.7× 159 0.4× 471 1.7× 350 2.1× 115 0.8× 73 1.4k
Yan Hu China 25 1.8k 1.7× 133 0.3× 302 1.1× 140 0.8× 202 1.5× 73 2.3k
Jingyi Yang China 19 814 0.8× 249 0.6× 149 0.5× 184 1.1× 49 0.4× 45 1.4k
Duk-Hwan Kim South Korea 26 1.3k 1.2× 387 0.9× 503 1.8× 426 2.5× 325 2.4× 64 2.1k
Minghui He China 15 862 0.8× 123 0.3× 254 0.9× 113 0.7× 104 0.8× 35 1.3k
Lan Zhong China 18 521 0.5× 250 0.6× 150 0.5× 121 0.7× 67 0.5× 50 983

Countries citing papers authored by Xiaofeng Jin

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Jin more than expected).

Fields of papers citing papers by Xiaofeng Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Jin. The network helps show where Xiaofeng Jin may publish in the future.

Co-authorship network of co-authors of Xiaofeng Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Jin. A scholar is included among the top collaborators of Xiaofeng Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Jin. Xiaofeng Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Bifeng, Qian Zhu, Yibo Geng, et al.. (2025). Improved estimation of soil organic carbon stock in subtropical cropland of Southern China based on digital soil mapping and multi-sources data. Geo-spatial Information Science. 28(6). 2864–2887. 1 indexed citations
2.
Yan, Chunhong, Shuyan Wang, Weili Yang, et al.. (2025). SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial cancer by inducing O-dysglycosylation. Oncogene. 44(22). 1694–1708.
3.
Wang, Jiahui, et al.. (2024). Roles of deubiquitinases in urologic cancers (Review). Oncology Letters. 28(6). 609–609. 1 indexed citations
4.
Yan, Huan, Xiang Wu, Hong Li, Zongdong Yu, & Xiaofeng Jin. (2024). Pan-Cancer Analysis Identifies BCLAF1 as a Potential Biomarker for Renal Cell Carcinoma. Biochemical Genetics. 63(2). 1479–1508.
5.
Kong, Lili & Xiaofeng Jin. (2024). Dysregulation of deubiquitination in breast cancer. Gene. 902. 148175–148175. 7 indexed citations
6.
Wang, Jie, Jingyi Xia, Chenlu Zhu, et al.. (2024). Low protein expression of LZTR1 in hepatocellular carcinoma triggers tumorigenesis via activating the RAS/RAF/MEK/ERK signaling. Heliyon. 10(12). e32855–e32855. 1 indexed citations
7.
He, Jian, et al.. (2023). The role of ubiquitination and deubiquitination in PI3K/AKT/mTOR pathway: A potential target for cancer therapy. Gene. 889. 147807–147807. 17 indexed citations
8.
Yan, Lin & Xiaofeng Jin. (2023). Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review). Experimental and Therapeutic Medicine. 27(1). 33–33. 3 indexed citations
9.
Li, Jingyun, et al.. (2023). Roles of estrogen receptor α in endometrial carcinoma (Review). Oncology Letters. 26(6). 530–530. 7 indexed citations
10.
Ye, Meng, et al.. (2023). The roles of FLOT1 in human diseases (Review). Molecular Medicine Reports. 28(5). 13 indexed citations
11.
Kong, Chunli, Xiaofeng Jin, Weiyue Chen, et al.. (2023). Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in Lung Cancer Patients. Academic Radiology. 30(12). 2880–2893. 8 indexed citations
12.
Ye, Meng, et al.. (2023). The crosstalk between ubiquitination and endocrine therapy. Journal of Molecular Medicine. 101(5). 461–486. 2 indexed citations
13.
Jin, Xiaofeng, et al.. (2022). Deregulation of SPOP in Cancer. Cancer Research. 83(4). 489–499. 37 indexed citations
14.
Yan, Lin, Qian Li, & Xiaofeng Jin. (2022). Kelch-like protein 3 in human disease and therapy. Molecular Biology Reports. 49(10). 9813–9824.
15.
16.
Zhu, Bo, Xiaoding Hu, Xiaofeng Jin, et al.. (2017). Knockout of the Nogo-B Gene Attenuates Tumor Growth and Metastasis in Hepatocellular Carcinoma. Neoplasia. 19(7). 583–593. 26 indexed citations
17.
Zhu, Jie, Fangfang Zhu, Wenfeng Song, et al.. (2016). Altered miR-370 expression in hepatic ischemia-reperfusion injury correlates with the level of nuclear kappa B (NF-κB) related factors. Gene. 607. 23–30. 20 indexed citations
18.
Peng, Jingtao, Jian Ma, Weiguo Li, et al.. (2015). Stabilization of MCRS1 by BAP1 prevents chromosome instability in renal cell carcinoma. Cancer Letters. 369(1). 167–174. 35 indexed citations
19.
Gao, Kun, Xiaofeng Jin, Jian Ma, et al.. (2015). Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover. Cell Death and Disease. 6(3). e1687–e1687. 50 indexed citations
20.
Jin, Xiaofeng. (2000). A comparison study on the hydrocarbon productivity of pollen and algae. Petroleum Exploration and Development. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaojun Zha Breakdown of academic impact, for papers by Dadong Zhang Breakdown of academic impact, for papers by Fangfang Liu Breakdown of academic impact, for papers by Yan Hu Breakdown of academic impact, for papers by Jingyi Yang Breakdown of academic impact, for papers by Duk-Hwan Kim Breakdown of academic impact, for papers by Minghui He Breakdown of academic impact, for papers by Lan Zhong
Rankless by CCL
2026